Prevention of Iron Deficiency in Breastfed Infants
1 other identifier
interventional
219
1 country
1
Brief Summary
With early screening and appropriate iron supplementation, iron deficiency in the first year of life can be prevented in breastfed infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Dec 2010
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 28, 2011
CompletedFirst Posted
Study publicly available on registry
September 30, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedMarch 31, 2017
March 1, 2017
3.3 years
September 28, 2011
March 29, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Iron deficiency anemia will be prevented in all infants before 5.5 mo of age
Iron deficiency anemia will be defined as plasma ferritin less than 10 ug/L and hemoglobin less than 105 g/L. The expected outcome is there will be no infants with iron deficiency anemia before 5.5 mo of age.
5.5 mo
Secondary Outcomes (1)
Determine the number of infants with iron deficiency between 5.5 and 9 mo of age
9 mo
Study Arms (2)
Intervention
ACTIVE COMPARATORFer-in-Sol drops and iron-fortified cereal
Control
OTHERNo intervention
Interventions
Fer-in-Sol drops providing 7.5 mg iron in 0.3 ml per day given from 84 to 168 d of age and iron-fortified cereal
Eligibility Criteria
You may qualify if:
- Term infants
- gestational age 37-42 weeks
- birth weight \> 2500 g
- exclusively breastfed at 28 d of age
- intend to breast feed until 9 mo of age
You may not qualify if:
- supplemental formula before 4 mo of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Iowa
Iowa City, Iowa, 52242, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ekhard Ziegler, MD
University of Iowa
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 28, 2011
First Posted
September 30, 2011
Study Start
December 1, 2010
Primary Completion
April 1, 2014
Study Completion
April 1, 2014
Last Updated
March 31, 2017
Record last verified: 2017-03